Collins M - Search Results

1

High-dose chemotherapy with autologous stem cell transplantation in relapsed or refractory germ cell tumours: outcomes and prognostic variables in a case series of 17 patients.

Lewin J, Dickinson M, Voskoboynik M, Collins M, Ritchie D, Toner G. Lewin J, et al. Among authors: collins m. Intern Med J. 2014 Aug;44(8):771-8. doi: 10.1111/imj.12486. Intern Med J. 2014. PMID: 24893627

2

Acute myeloid leukaemia relapsing after allogeneic haemopoietic stem cell transplantation: prognostic factors and impact of initial therapy of relapse.

Lim ABM, Curley C, Fong CY, Bilmon I, Beligaswatte A, Purtill D, Getta B, Johnston AM, Armytage T, Collins M, Mason K, Fielding K, Greenwood M, Gibson J, Hertzberg M, Wright M, Lewis I, Moore J, Curtis D, Szer J, Kennedy G, Ritchie D. Lim ABM, et al. Among authors: collins m. Intern Med J. 2018 Mar;48(3):276-285. doi: 10.1111/imj.13522. Intern Med J. 2018. PMID: 28628276

3

Older recipient age is paradoxically associated with a lower incidence of chronic GVHD in thymoglobulin recipients: a retrospective study exploring risk factors for GVHD in allogeneic transplantation with thymoglobulin GVHD prophylaxis.

Lim AB, Storek J, Beligaswatte A, Collins M, Tacey M, Williamson T, Mason K, Li E, Chaudhry MA, Russell JA, Daly A, Szer J, Lewis I, Ritchie D. Lim AB, et al. Among authors: collins m. Bone Marrow Transplant. 2015 Apr;50(4):566-72. doi: 10.1038/bmt.2014.313. Epub 2015 Feb 2. Bone Marrow Transplant. 2015. PMID: 25642763 Clinical Trial.

4

Intra-patient dose escalation in Ewing's sarcoma treated with vincristine, doxorubicin, cyclophosphamide alternating with ifosfamide and etoposide: a retrospective review.

Lewin J, Wieringa S, Collins M, Desai J, Orme L, Lingaratnam S, Thomas DM. Lewin J, et al. Among authors: collins m. Clin Sarcoma Res. 2013 Dec 10;3(1):15. doi: 10.1186/2045-3329-3-15. Clin Sarcoma Res. 2013. PMID: 24321600 Free PMC article.

5

Patients treated with platinum-doublet chemotherapy for advanced non--small-cell lung cancer have inferior outcomes if previously treated with platinum-based chemoradiation.

Paramanathan A, Solomon B, Collins M, Franco M, Kofoed S, Francis H, Ball D, Mileshkin L. Paramanathan A, et al. Among authors: collins m. Clin Lung Cancer. 2013 Sep;14(5):508-12. doi: 10.1016/j.cllc.2013.03.007. Epub 2013 Jun 20. Clin Lung Cancer. 2013. PMID: 23792009

6

A prospective comparison of times to presentation and treatment of regional and remote head and neck patients in North Queensland, Australia.

Tan JY, Otty ZA, Vangaveti VN, Buttner P, Varma SC, Joshi AJ, Kelly J, Collins M, Sabesan SS. Tan JY, et al. Among authors: collins m. Intern Med J. 2016 Aug;46(8):917-24. doi: 10.1111/imj.13138. Intern Med J. 2016. PMID: 27246246

7

A phase II study of induction carboplatin and gemcitabine followed by chemoradiotherapy for the treatment of locally advanced nasopharyngeal carcinoma.

Lim AM, Corry J, Collins M, Peters L, Hicks RJ, D'Costa I, Coleman A, Chua M, Solomon B, Rischin D. Lim AM, et al. Among authors: collins m. Oral Oncol. 2013 May;49(5):468-74. doi: 10.1016/j.oraloncology.2012.12.012. Epub 2013 Jan 29. Oral Oncol. 2013. PMID: 23369852 Clinical Trial.

8

Lung cancer patients in Queensland suffer delays in receiving radiation therapy--but not as a result of distance.

Burmeister BH, Zarate DD, Burmeister EA, Harden HE, Colquist SP, Cossio DL, Poulsen MG, Collins M, Pratt GR, Walpole ET. Burmeister BH, et al. Among authors: collins m. Intern Med J. 2010 Feb;40(2):126-32. doi: 10.1111/j.1445-5994.2009.01912.x. Epub 2009 Feb 13. Intern Med J. 2010. PMID: 19220556

9

T4 squamous cell carcinoma of the oral tongue without mandibular involvement: surgery or chemoradiotherapy?

McDowell L, Collins M, Kleid S, Rischin D, Corry J. McDowell L, et al. Among authors: collins m. Oral Surg Oral Med Oral Pathol Oral Radiol. 2014 Feb;117(2):163-9. doi: 10.1016/j.oooo.2013.09.005. Epub 2013 Nov 23. Oral Surg Oral Med Oral Pathol Oral Radiol. 2014. PMID: 24275355

10

Use of arsenic trioxide in remission induction and consolidation therapy for acute promyelocytic leukaemia in the Australasian Leukaemia and Lymphoma Group (ALLG) APML4 study: a non-randomised phase 2 trial.

Iland HJ, Collins M, Bradstock K, Supple SG, Catalano A, Hertzberg M, Browett P, Grigg A, Firkin F, Campbell LJ, Hugman A, Reynolds J, Di Iulio J, Tiley C, Taylor K, Filshie R, Seldon M, Taper J, Szer J, Moore J, Bashford J, Seymour JF; Australasian Leukaemia and Lymphoma Group. Iland HJ, et al. Among authors: collins m. Lancet Haematol. 2015 Sep;2(9):e357-66. doi: 10.1016/S2352-3026(15)00115-5. Epub 2015 Aug 20. Lancet Haematol. 2015. PMID: 26685769 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

5,302 results

Search Page

Filters